Bcl-2 positivity in B and C Hepatitis and hepatocellular carcinomas

Hepato-Gastroenterology

Volumn 55, Issue 88, 2008, Pages 2207-2210

  Yildiz, Levent ^a   Baris, Sancar ^a   Aydin, Oguz ^a   Kefeli, Mehmet ^a   Kandemir, Bedri ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Bcl 2; Hepatitis B; Hepatitis C; Hepatocellular carcinoma

Indexed keywords

PROTEIN BCL 2;

ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 60849094814     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bakkenist CJ, McGee JO'D: Molecular genetics of hepatocellular carcinoma. In: Tahara E, ed. Molecular Pathology of Gastroenterological Cancer. Application to Clinical Practice Tokyo: Springer, 1997; 219-243.
2. Dutta U, Kench J, Byth K, Khan MH, Lin R, Liddle C, et al: Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study on chronic hepatitis C. Hum Pathol 1998; 29:1279-1284.
3. Lu QI-L, Abel P, Foster CS, Lalani N: Bcl-2: Role in epithelial differentiation and oncogenesis. Hum Pathol 1996; 27:102-110.
4. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Galvard P, et al: Immunohistochemical detection of bcl-2 protein in normal and pathological liver. Am J Pathol 1994; 114:460-465.
5. Strasser A, Harris AW, Bath ML, Cory S: Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 1990; 348:331-333.
6. Martin JM, Veis D, Korsmeyer SJ, Suqden B: Latent membrane protein of EBV induces cellular phenotypes independently of expression of bcl-2. J Virol 1993; 67:5269-5278.
7. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335:440-442.
8. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al: Tumor supressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9:1799-1805.
9. Nakagawa K, Yamamura K, Maeda S, Ichihashi M: bcl-2 expression in epidermal keratinocytic diseases. Cancer 1994; 74:1770-1724.
10. Gompel A, Sabourin JC, Martin A, Yaneva H, Audouin J, Decroix Y, et al: bcl-2 experience in normal endometrium during the menstrual cycle. Am J Pathol 1994; 144:1135-1142.
11. Zhao MM, Zhang NX, Economou M, Blaba I, Laissue JA, Zimmermann A: Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994; 25:237-245.
12. Lee SH, Shin MS, Lee HS, Bae JH, Lee HK, Kim HS, et al: Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol 2001; 32:250-256.
13. Mutluay R, Ozenirler S, Poyraz A: The expression of bcl-2 in chronic liver diseases. Saudi Med J 2005; 26:1245-1249.